治疗功效和可能的机制的武胡底层喘进展通过Th1/Th2失衡不平衡
Yan Hu1, Mengqing Wang1, Yinhe Luo2
1Department of Pediatrics, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, China.
Journal of thoracic disease
|February 20, 2025
概括
武胡显示出治疗喘 (CVA) 的治疗潜力,通过改善呼吸道的高反应性和炎症. 它通过抑制IncTRPM2-AS来起作用,这是喘模型中Th1/Th2平衡的关键调节剂.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 传统中国医药 传统中国医药
背景情况:
- 咳变异性喘 (CVA) 缺乏确定的诊断和有效的治疗方法.
- 传统中医药的Wuhu,对CVA有前途,但其机制尚不清楚.
研究的目的:
- 为了研究武侯的治疗潜力,对抗心血管疾病.
- 阐明CVA治疗中Wuhu的潜在分子机制.
主要方法:
- 使用卵胺 (OVA) 敏感化建立了一个CVA小鼠模型.
- 评估了呼吸道过敏反应,炎症和重塑.
- 量化炎症细胞,IgE,T细胞子集,细胞因子和lncTRPM2-AS表达.
主要成果:
- 武胡改善了OVA诱导的喘小鼠的气道过敏反应和重塑.
- 它调节了Th1/Th2平衡,减少了肺炎性损伤.
- 武胡制剂抑制了IncTRPM2-AS表达,这是Th1/Th2平衡的关键调节器.
结论:
- 在小鼠模型中,Wuhu液显示了对CVA的保护作用.
- 该机制涉及通过抑制lncTRPM2-AS.调节Th1/Th2平衡.
- 突出了武胡的治疗潜力,用于治疗喘.
相关概念视频
Asthma: Pathogenesis and Management
339
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
339
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231
Antiasthma Drugs: Leukotriene Modifiers
238
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
238
Antiasthma Drugs: Methylxanthines
187
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
187
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


